xi's moments
Home | Americas

Japan's Kobayashi Pharma chairman, president step d8k8 jiliown over supplement scandal

深圳安居集团发文收购商品房用作保障房,这会给当地房地产市场带来哪些影响? | 8k8 jili | Updated: 2024-08-08 12:24:20

This file photo taken on March 29, 2024 shows Kobayashi Pharmaceutical Co. president Akihiro Kobayashi (2nd L) and others bowing their heads at the beginning of a press conference in Osaka. [Photo/Agencies]

TOKYO - Japanese drugmaker Kobayashi Pharmaceutical Co. said Tuesday the company's chairman and its president resigned to take responsibility for health problems and deaths that could be linked to the consumption of its red yeast rice dietary supplements.

The resignations of Chairman Kazumasa Kobayashi and President Akihiro Kobayashi, both members of the company's founding family, were approved at a special meeting of the board of directors earlier on the day.

The Osaka-based pharmaceutical giant also released an investigation report over its handling of the issue, acknowledging delays in alerting consumers to potential risks and recalling their products.

Meanwhile, 64-year-old Satoshi Yamane, senior executive director of Kobayashi Pharmaceutical, has been promoted to the company's president, making him the first person outside the company's founding family to serve in the post.

After stepping down, Kazumasa, 84, will become a special adviser, while Akihiro, 53, will give up the authority to represent the company but remain as a director to respond to compensation for health hazards caused by the supplement.

According to Kobayashi Pharmaceutical, the number of deaths that need to be investigated in connection with the consumption of its supplements reached 101 as of Sunday, including four people that the company announced in March that had died after taking its dietary supplements with red yeast rice, or beni-koji.

现代人为什么都那么喜欢「李白」,「李白」的诗你最喜欢哪首?为什么喜欢?
Global Edition
BACK TO THE TOP
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349